Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology

Product News   Apr 23, 2018

 
Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Sekisui XenoTech Receives New US Patent for Kit and Method to Evaluate Xenobiotic Drug Metabolism in Hepatocytes

Product News

Sekisui XenoTech has been awarded US patent # 10,001,471 “In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes.”

READ MORE

Axol Bioscience Launch Human iPSC-derived Atrial Cardiomyocytes

Product News

A consistent and reproducible model for drug development, toxicity testing and disease modelling applications.

READ MORE


Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy